期刊
BREAST
卷 21, 期 3, 页码 242-252出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.breast.2012.03.003
关键词
Advanced breast cancer; Metastatic breast cancer; Guidelines; Consensus; ABC 1
资金
- Abraxis
- Amgen
- AstraZeneca
- Bayer Schering
- Bristol Myers
- Celgene
- Cephalon
- GSK
- Helsinn
- Hospira
- Johnson and Johnson
- Ortho Biotech
- Merck
- MSD
- Novartis
- Pfizer
- Pierre-Fabre
- Roche
- Sandoz
- Schering
- Sanofi-Aventis
- Vifor
- Breast Oncology Center
- Dana-Farber Cancer Institute
- Boston
- U.S. Genentech
- Boehringer Ingelheim
- Bayer
- Genentech/Roche
- Merck, Novartis, BMS
- Sanofi/Bipar
- Lilly/Imclone
The 1st international Consensus Conference for Advanced Breast Cancer (ABC 1) took place on November 2011, in Lisbon. Consensus guidelines for the management of this disease were developed. This manuscript summarizes these international consensus guidelines. (C) 2012 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
